Back to STATE STREET CORP STATE STREET CORP

GYREGYRE
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in GYRE THERAPEUTICS INC

STATE STREET CORP holds 245,402 shares of GYRE (GYRE THERAPEUTICS INC), worth $1.6M as of 2026-Q2. The position was increased (+13.4% shares).

Current Value

$1.6M

Current Shares

245,402

Total Value Change

+$1.2M

Total Shares Change

+231,064

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
245,402
+13.4%
$1.6M0.0%$6.59
20
2026-Q1
Increased
216,326
+7.0%
$1.5M0.0%$6.97
27
2025-Q4
Increased
202,225
+10.7%
$1.4M0.0%$7.06
19
2025-Q3
Increased
182,753
+2.8%
$1.4M0.0%$7.46
18
2025-Q2
Increased
177,768
+38.0%
$1.3M0.0%$7.35
23
2025-Q1
Increased
128,773
+1.7%
$994,1280.0%$7.72
17
2024-Q4
Increased
126,647
+21.2%
$1.5M0.0%$12.10
31
2024-Q3
Increased
104,490
+8.8%
$1.3M0.0%$12.54
28
2024-Q2
Increased
96,078
+137.0%
$1.1M0.0%$11.93
41
2024-Q1
Increased
40,538
+182.7%
$708,6040.0%$17.48
27
2023-Q4
New
14,338
-
$368,3430.0%$25.69
36

Other major holders of GYRE: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used